A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
Larry Bellot
Advertisement
Larry Bellot, PhD, is scientific advisor, Cell and Gene Therapy, at Charles River Laboratories.
Articles by Larry Bellot
Advertisement
Latest Updated Articles
Advertisement
Advertisement
